咳止めの世界市場

咳止めの世界市場は2030年までに12億米ドルに達する見込み

2024年に10億米ドルと推定される咳止めの世界市場は、2024年から2030年にかけてCAGR 2.6%で成長し、2030年には12億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである去痰薬は、CAGR 3.1%を記録し、分析期間終了時には5億7,330万米ドルに達すると予測されます。抗ヒスタミン薬セグメントの成長率は、分析期間中CAGR 2.9%と推定されます。

米国市場は2億8,120万米ドルと推定、中国はCAGR 5.1％で成長予測

米国の咳止め市場は、2024年に2億8,120万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR5.1％を追いかけ、2030年までに2億3,300万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ0.9%と2.0%と予測されています。欧州では、ドイツがCAGR 1.4%で成長すると予測されています。

世界の咳止め市場- 主要動向と促進要因まとめ

なぜ咳止め薬は世界のヘルスケアおよびウェルネス市場において永続的なセグメントなのか？

咳止めは、あらゆる年齢層や地域において咳が普遍的かつ反復的に発生することから、OTCヘルスケア製品の重要な構成要素であり続けています。風邪、アレルギー、喘息、インフルエンザ、環境汚染物質など、咳は症状を和らげようとする人にとって最も一般的な症状のひとつです。この持続的な需要により、咳止めシロップ、トローチ、去痰薬、充血除去薬、配合薬の市場は安定しています。OTC咳止め薬は薬局、スーパーマーケット、オンライン・プラットフォームで入手しやすいため、世界的に最も購入されているセルフ・ケアソリューションのひとつとなっています。さらに、健康意識の高まりから呼吸器症状の早期治療が増加し、家庭の薬箱に咳止めを常備する消費者が増えています。特に冬とインフルエンザの季節には、呼吸器感染症が季節的に急増するため、需要が常に高まっています。特に小児と老年人口は、強い副作用なしに症状を和らげることができるマイルドで特殊な製剤に大きく依存しています。さらに、市場はハーブ、ナチュラル、砂糖不使用のものへと進化し、穏やかでホリスティックなヘルスケアへの嗜好の高まりに対応しています。最前線の症状緩和薬として、また日常の健康習慣に深く浸透している製品として、咳止め薬は世界の医薬品・消費者用医薬品のポートフォリオに不可欠かつ大量に含まれるカテゴリーであり続けています。

消費者の嗜好の変化やライフスタイルの動向は、咳止め市場にどのような影響を与えていますか？

咳止め市場は、即効性があり、眠くならず、自然で、個人に合った治療法を好む現代の消費者行動によってますます形成されつつあります。消費者が成分をより意識するようになるにつれ、蜂蜜、生姜、メントール、ユーカリ、アイビーの葉、甘草の根などの天然成分を特徴とする治療薬へのシフトが顕著であり、多くの場合、化学薬品ベースの医薬品よりも安全で優しい代替品として認識されています。この動向は、特にミレニアル世代や幼い子どもを持つ親の間で顕著で、彼らは合成添加物の少ない自然な処方を好みます。また、多忙なライフスタイルは、溶解可能なストリップ、トローチ、1回分ずつ服用する小袋など、携帯可能で使いやすい形態への需要を促進しています。同時に、デジタル・ウェルネス文化や自己診断の習慣により、消費者は症状の特異性に基づいて治療薬を自己選択するようになり、ブランドは明確にセグメント化された製品（乾いた咳と胸が苦しい咳、日中用と夜間用など）を提供するようになっています。ビーガン、シュガーフリー、グルテンフリー、アルコールフリーの表示は、さまざまな食生活や倫理的な消費者グループへのアピールをさらに強めています。COVID-19の後、呼吸器系の健康に対する意識が高まり、軽度の症状であれば先手を打って治療する傾向が強まるなど、より慎重な行動が見られるようになりました。こうした嗜好の変化は、製薬会社やウェルネス・ブランドに、よりクリーンなラベル、多機能な効能、使いやすいデリバリー・システムといった革新を促し、咳止め薬の処方、販売、消費のあり方を一新しています。

咳止め薬の有効性と安全性を形成しているイノベーションと規制開発とは？

咳止め市場における技術革新は、薬理学的処方や植物学的研究から規制監督や製造技術に至るまで、多方面にわたって進展しています。科学者やメーカーは、眠気や胃腸の不快感などの副作用を最小限に抑えつつ効能を高めるため、合成および植物由来の新しい有効成分を絶えず探求しています。最近の製剤は、治療を簡略化し、患者のコンプライアンスを高めるために、複数の作用（去痰薬、抗ヒスタミン薬、鎮咳薬）を1回の服用で組み合わせることが多いです。さらに、成分の治療効果を長持ちさせ、投与回数を減らして利便性を向上させるために、カプセル化技術や時間放出技術が開発されています。規制面では、FDA（米国）、EMA（欧州）、MHRA（英国）などの機関が、コデインやデキストロメトルファンなど特定の成分について、特に青少年の誤用への懸念から規制を強化しています。その結果、安全で習慣性のない代替品や、用法・用量の明確な表示がますます重視されるようになっています。GMP（医薬品の製造管理及び品質管理に関する基準）やISO（国際標準化機構）規格などの品質認証は、現在、従来の医薬品・漢方薬の製造業者にとって基本的な要件となっています。新興市場では、規制の枠組みが改善され、公衆衛生への投資が増加したことで、より信頼性が高く、試験済みで、コンプライアンスに準拠した製品の導入が可能となっています。これらの開発により、咳止め薬は有効性に対する現代の期待に応えるだけでなく、世界ヘルスケアにおける安全性と透明性の進化する基準にも合致するようになっています。

世界の咳止め市場の成長を促進する主な要因は？

咳止め市場の成長は、持続的な需要と市場拡大を確実にする医療、人口統計、環境、経済的要因の組み合わせによってもたらされます。この感染症は毎年数百万人が罹患しており、医師の診察やOTC医薬品の購入の最も一般的な理由の一つとなっています。公害、季節性アレルゲン、気候変動などの環境的誘因は、アレルギー性鼻炎や気管支炎のような慢性呼吸器疾患の増加に寄与しています。これと並行して、発展途上諸国では人口増加と都市化が進み、特にヘルスケアへのアクセスが改善し医薬品流通チャネルが深まるにつれて、咳止め薬の消費者基盤が拡大しています。世界のヘルスリテラシーの向上と予防的ヘルスケア行動により、消費者は早期の症状緩和を求めるようになり、OTC薬や天然咳止め薬の需要を押し上げています。さらに、オンライン・プラットフォーム、小売店、薬局チェーンで製品を入手できるようになったことで、特にこれまでは十分なサービスを受けられなかった地域で、認知度が高まり、購入しやすくなっています。戦略的マーケティング、有名人の推薦、医療インフルエンサーとの提携も、消費者の信頼構築とブランド認知の促進に一役買っています。呼吸器系の健康が世界のウェルネス意識の最前線にある中、咳止め市場は従来型、ハーブ型、ハイブリッド型の製品カテゴリーにわたって継続的な成長が見込まれています。

セグメント

製品タイプ（去痰薬、抗ヒスタミン薬、気管支拡張薬、充血除去薬、抗生物質）、年齢層（小児、成人）、流通チャネル（小売薬局、病院薬局、オンライン薬局）

調査対象企業の例（合計 47注目の企業）

• AbbVie Inc.
• Astellas Pharma Inc.
• Bayer AG
• Bristol Myers Squibb
• Douglas Pharmaceuticals
• Eisai Co., Ltd.
• GSK plc
• Haleon plc
• Johnson & Johnson
• Kyowa Kirin Co., Ltd.
• Merck KGaA
• Perrigo Company plc
• Pfizer Inc.
• Reckitt Benckiser Group plc
• Ricola Ltd.
• Sanofi S.A.
• Takeda Pharmaceutical Co.
• Teva Pharmaceutical Industries Ltd.
• Vicks（Procter & Gamble）
• Wockhardt Ltd.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Cough Remedy Market to Reach US$1.2 Billion by 2030

The global market for Cough Remedy estimated at US$1.0 Billion in the year 2024, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 2.6% over the analysis period 2024-2030. Expectorants, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$573.3 Million by the end of the analysis period. Growth in the Antihistamine segment is estimated at 2.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$281.2 Million While China is Forecast to Grow at 5.1% CAGR

The Cough Remedy market in the U.S. is estimated at US$281.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$233.0 Million by the year 2030 trailing a CAGR of 5.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 2.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.4% CAGR.

Global Cough Remedy Market - Key Trends & Drivers Summarized

Why Are Cough Remedies an Enduring Segment in Global Healthcare and Wellness Markets?

Cough remedies continue to be a vital component of over-the-counter (OTC) healthcare products due to the universal and recurrent nature of coughs across all age groups and geographies. Whether triggered by the common cold, allergies, asthma, flu, or environmental pollutants, coughs are among the most common symptoms prompting individuals to seek relief. This enduring demand ensures a steady market for cough syrups, lozenges, expectorants, decongestants, and combination remedies. The accessibility of OTC cough medications in pharmacies, supermarkets, and online platforms makes them one of the most purchased self-care solutions globally. Additionally, rising health awareness has led to increased early treatment of respiratory symptoms, prompting more consumers to keep cough remedies in their household medicine cabinets year-round. Seasonal surges in respiratory infections-especially during winter and flu seasons-consistently drive spikes in demand. Pediatric and geriatric populations, in particular, rely heavily on mild and specialized formulations that can soothe symptoms without strong side effects. Furthermore, the market has evolved to include herbal, natural, and sugar-free variants, catering to the growing preferences for gentle and holistic healthcare. As both a frontline symptom-reliever and a product deeply embedded in daily wellness routines, cough remedies remain an essential and high-volume category in global pharmaceutical and consumer health portfolios.

How Are Shifting Consumer Preferences and Lifestyle Trends Influencing the Cough Remedy Market?

The cough remedy market is increasingly shaped by modern consumer behavior, which favors fast-acting, non-drowsy, natural, and personalized treatment options. As consumers become more ingredient-conscious, there is a marked shift toward remedies that feature natural components such as honey, ginger, menthol, eucalyptus, ivy leaf, and licorice root-often perceived as safer and gentler alternatives to chemical-based medicines. This trend is particularly pronounced among millennials and parents of young children, who prefer natural formulations with fewer synthetic additives. Busy lifestyles are also driving demand for portable and easy-to-use formats, such as dissolvable strips, lozenges, and single-dose sachets. In tandem, digital wellness culture and self-diagnosis habits have empowered consumers to self-select remedies based on symptom specificity, encouraging brands to offer clearly segmented products (e.g., dry cough vs. chesty cough, daytime vs. nighttime). Vegan, sugar-free, gluten-free, and alcohol-free labels are further enhancing appeal across various dietary and ethical consumer groups. In the wake of COVID-19, heightened awareness around respiratory health has led to more cautious behavior, with individuals more likely to treat mild symptoms preemptively. These evolving preferences are encouraging pharmaceutical companies and wellness brands to innovate with cleaner labels, multifunctional benefits, and user-friendly delivery systems-reshaping how cough remedies are formulated, marketed, and consumed.

What Innovations and Regulatory Developments Are Shaping the Efficacy and Safety of Cough Remedies?

Innovation in the cough remedy market is advancing on multiple fronts, from pharmacological formulations and botanical research to regulatory oversight and manufacturing technology. Scientists and manufacturers are continually exploring new active ingredients-both synthetic and plant-derived-to enhance efficacy while minimizing side effects such as drowsiness or gastrointestinal discomfort. Modern formulations often combine multiple actions (expectorant, antihistamine, antitussive) in a single dose to simplify treatment and increase patient compliance. Furthermore, encapsulation and time-release technologies are being developed to prolong the therapeutic effects of ingredients, reducing the frequency of doses and improving convenience. On the regulatory side, agencies such as the FDA (U.S.), EMA (Europe), and MHRA (UK) have tightened controls on specific ingredients like codeine and dextromethorphan due to concerns around misuse, particularly among adolescents. As a result, there is an increasing emphasis on safe, non-habit-forming alternatives and clearer dosage labeling. Quality certifications such as GMP (Good Manufacturing Practice) and ISO standards are now baseline requirements for both conventional and herbal remedy producers. In emerging markets, improved regulatory frameworks and increased public health investment are enabling the introduction of more reliable, tested, and compliant products. Together, these developments are ensuring that cough remedies not only meet modern expectations for effectiveness but also align with evolving standards of safety and transparency in global healthcare.

What Are the Primary Drivers Fueling the Growth of the Global Cough Remedy Market?

The growth in the cough remedy market is driven by a combination of medical, demographic, environmental, and economic factors that ensure sustained demand and market expansion. One of the core drivers is the persistent prevalence of upper respiratory tract infections worldwide, which continue to affect millions annually and remain one of the most common reasons for doctor visits and OTC purchases. Environmental triggers such as pollution, seasonal allergens, and climate change are contributing to an increase in chronic respiratory conditions like allergic rhinitis and bronchitis-conditions where cough is a frequent symptom. In parallel, population growth and urbanization in developing countries are expanding the consumer base for cough remedies, especially as healthcare access improves and pharmaceutical distribution channels deepen. The global rise in health literacy and preventive healthcare behaviors is encouraging consumers to seek early symptom relief, which boosts demand for OTC and natural cough medications. Furthermore, product availability across online platforms, retail stores, and pharmacy chains is increasing visibility and ease of purchase, especially in previously underserved regions. Strategic marketing, celebrity endorsements, and medical influencer partnerships are also playing a role in building consumer trust and driving brand recognition. With respiratory health at the forefront of global wellness consciousness, the market for cough remedies is poised for continued growth across conventional, herbal, and hybrid product categories.

SCOPE OF STUDY:

The report analyzes the Cough Remedy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Expectorants, Antihistamine, Bronchodilator, Decongestant, Antibiotic); Age Group (Pediatric, Adult); Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

• AbbVie Inc.
• Astellas Pharma Inc.
• Bayer AG
• Bristol Myers Squibb
• Douglas Pharmaceuticals
• Eisai Co., Ltd.
• GSK plc
• Haleon plc
• Johnson & Johnson
• Kyowa Kirin Co., Ltd.
• Merck KGaA
• Perrigo Company plc
• Pfizer Inc.
• Reckitt Benckiser Group plc
• Ricola Ltd.
• Sanofi S.A.
• Takeda Pharmaceutical Co.
• Teva Pharmaceutical Industries Ltd.
• Vicks (Procter & Gamble)
• Wockhardt Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Cough Remedy - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Respiratory Infections Throws the Spotlight on Fast-Acting Cough Relief Products
  • Consumer Shift Toward Herbal and Natural Remedies Drives Demand for Plant-Based Cough Treatments
  • Surge in Pediatric and Geriatric Populations Propels Growth in Age-Specific Cough Formulations
  • Expansion of E-Commerce Channels Accelerates Availability and Market Penetration of OTC Cough Remedies
  • Seasonal Allergies and Urban Pollution Trends Strengthen the Business Case for Chronic Cough Relief Solutions
  • Push for Sugar-Free and Alcohol-Free Formulations Drives Innovation in Health-Conscious Syrups and Lozenges
  • Increased Awareness of Antimicrobial Resistance Spurs Preference for Non-Antibiotic Cough Relief Options
  • Growth in Functional Beverages and Gummies Expands Format Diversity in the Cough Remedy Market
  • Focus on Respiratory Health Consciousness Sustains Long-Term Demand for Immune-Supportive Cough Products
  • Pharmacy Chains and Private Label Expansion Drive Competitive Pricing in Key Cough Remedy Segments
  • Rise in Travel Generates Demand for Portable, Travel-Sized Cough Relief SKUs
  • Rising Demand for Rapid-Onset Relief Enhances the Appeal of Fast-Dissolving and Inhalable Cough Formats
  • Integration of Traditional Medicine Practices Spurs Growth in Ayurveda, TCM, and Homeopathy-Based Formulations
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Cough Remedy Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Cough Remedy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Cough Remedy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Cough Remedy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Expectorants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Expectorants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Expectorants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Antihistamine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Antihistamine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Antihistamine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Bronchodilator by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Bronchodilator by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Bronchodilator by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Decongestant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Decongestant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Decongestant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Antibiotic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Antibiotic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Antibiotic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Online Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Online Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Online Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Retail Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Retail Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Retail Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Hospital Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Pediatric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Adult by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• JAPAN
  • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• CHINA
  • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• EUROPE
  • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Cough Remedy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Cough Remedy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Cough Remedy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• FRANCE
  • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• GERMANY
  • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Cough Remedy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Cough Remedy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Cough Remedy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• INDIA
  • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Cough Remedy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Cough Remedy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Cough Remedy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Cough Remedy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Cough Remedy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Cough Remedy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
• AFRICA
  • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030

IV. COMPETITION